Women's Health

Test Code: 4021

CPT Code(s): 82670

Methodology: Immunoassay (IA)

Test Code: 746

CPT Code(s): 84146

Methodology: Immunoassay (IA)

Test Code: 745

CPT Code(s): 84144

Methodology: Immunoassay

Clinical Significance: Levels increase sharply during the luteal phase of the menstrual cycle. The level increases from 9 to 32 weeks of pregnancy.

Alternative Name(s): N/A

Test Code: 7137

CPT Code(s): 83001, 83002

Methodology: Immunoassay

Test Code: 8477

CPT Code(s): 82950

Methodology: Spectrophotometry (SP)

Clinical Significance: A value of 135 mg/dL or greater indicates the need for a full diagnostic, gestational glucose tolerance performed in the fasting state to determine if the patient has gestational diabetes.

Test Code: 8396

CPT Code(s): 84702

Methodology: Immunoassay (IA)

Limitations: Heterophilic antibodies may produce low false-positive results; urinary hCG is negative if "phantom" hCG is suspected. Pituitary secretion may be a source of low level hCG in post menopausal women

Test Code: 91932

CPT Code(s): 87624

Includes: HPV Mrna e6/e7, Rectal

Methodology: Transcription-Mediated Amplification (TMA)

Clinical Significance: The HPV mRNA E6/E7 test is used in conjunction with cytology to evaluate anal dysplasia.

Alternative Name(s): Human Papillomavirus

Test Code: 20210

CPT Code(s): 80055, 85025, 86592, 86762, 86850, 86900, 86901, 87340

Includes:
CBC (includes Differential and Platelets)

Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typing

ABO Group and Rh Type

RPR (Diagnosis) with Reflex to Titer and Confirmatory Testing

Hepatitis B Surface Antigen with Reflex Confirmation*

Rubella Virus IgG Antibody

Test Code: 6447

CPT Code(s): 86695, 86696

Methodology: Immunoassay (IA)

Test Code: 91476

CPT Code(s): 87996 (x2)

Includes: U. parvum DNA, U urealyticum DNA

Methodology: Real-Time Polymerase Chain Reaction (RT-PCR)

Clinical Significance: Ureaplasma spp has been associated with genital tract infection and infertility.

Alternative Names: None